Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation

Matthew H.G. Katz, Gauri R. Varadhachary, Jason B. Fleming, Robert A. Wolff, Jeffrey E. Lee, Peter W.T. Pisters, Jean Nicolas Vauthey, Eddie K. Abdalla, Charlotte C. Sun, Huamin Wang, Christopher H. Crane, Jeffrey H. Lee, Eric P. Tamm, James L. Abbruzzese, Douglas B. Evans

Research output: Contribution to journal › Article › peer-review

132 Scopus citations

Fingerprint

Dive into the research topics of 'Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation'. Together they form a unique fingerprint.

Medicine & Life Sciences